FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2429123395> ?p ?o ?g. }

• W2429123395 endingPage "1937" @default.
• W2429123395 startingPage "1932" @default.
• W2429123395 abstract "No AccessJournal of Urology1 Dec 1993Dissecting the Immunobiological Effects of Bacillus Calmette-Guérin (BCG) In Vitro: Evidence of a Distinct BCG-Activated Killer (BAK) Cell Phenomenon A. Böhle, A. Thanhäuser, A.J. Ulmer, M. Ernst, H.-D. Flad, and D. Jocham A. BöhleA. Böhle More articles by this author , A. ThanhäuserA. Thanhäuser More articles by this author , A.J. UlmerA.J. Ulmer More articles by this author , M. ErnstM. Ernst More articles by this author , H.-D. FladH.-D. Flad More articles by this author , and D. JochamD. Jocham More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)35941-4AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Several immunobiological effects of intravesical bacillus Calmette-Guérin (BCG) during immunotherapy of superficial bladder cancer have been suggested as possible mediators of the mode of action. In an attempt to elucidate which of these effects is relevant to tumoricidal activity, an in vitro cytotoxicity assay was employed in which the direct effects of BCG and of cytokines against four transitional carcinoma cell lines were studied. Furthermore, peripheral blood mononuclear cells (PBMNC) were analyzed for their cytotoxic potential against these target cells. We found that none of the cytokines interleukin-1, interleukin-2, interferon-gamma, tumor necrosis factor alpha, lymphotoxin, or BCG alone were cytotoxic against the bladder carcinoma cell lines. However, a pronounced cytotoxicity against these targets resistant to natural killer cells could be induced in PBMNC by coincubation with viable BCG. We termed this the BCG-activated killer (BAK) cell phenomenon. In contrast to lymphokine-activated (LAK) cells, these BAK cells needed prolonged activation for 7 days and did not enhance the cytotoxicity against K562 target cells sensitive to natural killer cells. Nonviable, heat-inactivated BCG was significantly less effective, and sonificated fractions of BCG were not effective in stimulating PBMNC towards BAK cell activity. In vitro dissection of effects observed during BCG intravesical therapy may give more insight into the mode of action of BCG and may help to separate primary tumoricidal effector mechanisms from secondary concomitant phenomena. Further characterization of the BAK cell may result in an improvement of intravesical BCG immunotherapy. © 1993 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited bySecanella-Fandos S, Noguera-Ortega E, Olivares F, Luquin M and Julián E (2018) Killed but Metabolically Active Mycobacterium bovis bacillus Calmette-Guérin Retains the Antitumor Ability of Live bacillus Calmette-GuérinJournal of Urology, VOL. 191, NO. 5, (1422-1428), Online publication date: 1-May-2014.SAINT F, PATARD J, MAILLE P, SOYEUX P, HOZNEK A, SALOMON L, ABBOU C and CHOPIN D (2018) PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCERJournal of Urology, VOL. 167, NO. 1, (364-367), Online publication date: 1-Jan-2002.KAASINEN E, HARJU L and TIMONEN T (2018) Inhibition Of Natural, Interleukin-2 Stimulated and Bacillus Calmette-Guerin Enhanced Cytotoxicity With Anti-CD16 AntibodiesJournal of Urology, VOL. 167, NO. 5, (2209-2214), Online publication date: 1-May-2002.Soloway M, Sofer M and Vaidya A (2018) Contemporary Management Of Stage T1 Transitional Cell Carcinoma Of The BladderJournal of Urology, VOL. 167, NO. 4, (1573-1583), Online publication date: 1-Apr-2002.BÖHLE A, BÜTTNER H and JOCHAM D (2018) PRIMARY TREATMENT OF CONDYLOMATA ACUMINATA WITH VIABLE BACILLUS CALMETTE-GUERINJournal of Urology, VOL. 165, NO. 3, (834-836), Online publication date: 1-Mar-2001.BRAKE M, LOERTZER H, HORSCH R and KELLER H (2018) RECURRENCE AND PROGRESSION OF STAGE T1, GRADE 3 TRANSITIONAL CELL CARCINOMA OF THE BLADDER FOLLOWING INTRAVESICAL IMMUNOTHERAPY WITH BACILLUS CALMETTE-GUERINJournal of Urology, VOL. 163, NO. 6, (1697-1701), Online publication date: 1-Jun-2000.KAASINEN E, HARJU L, ALFTHAN O and TIMONEN T (2018) NON-SPECIFIC, RAPIDLY GENERATED CYTOTOXICITY IN LYMPHOCYTES INDUCED BY BCG IN VITRO: NO EVIDENCE OF ENHANCING EFFECT FROM PRECEDING INTERACTION BETWEEN BCG AND TRANSITIONAL CELL LINE CELLSJournal of Urology, VOL. 163, NO. 1, (317-322), Online publication date: 1-Jan-2000.ZHANG Y, KHOO H and ESUVARANATHAN K (2018) EFFECTS OF BACILLUS CALMETTE-GUERIN AND INTERFERON alpha-2B ON CYTOKINE PRODUCTION IN HUMAN BLADDER CANCER CELL LINESJournal of Urology, VOL. 161, NO. 3, (977-983), Online publication date: 1-Mar-1999.DUREK C, BRANDAU S, ULMER A, FLAD H, JOCHAM D and BOHLE A (2018) BACILLUS-CALMETTE-GUERIN (BCG) AND 3D TUMORS: AN IN VITRO MODEL FOR THE STUDY OF ADHESION AND INVASIONJournal of Urology, VOL. 162, NO. 2, (600-605), Online publication date: 1-Aug-1999.Bohle A, Rusch-Gerdes S, Ulmer A, Braasch H and Jocham D (2018) The Effect of Lubricants on Viability of Bacillus Calmette-Guerin for Intravesical Immunotherapy Against Bladder CarcinomaJournal of Urology, VOL. 155, NO. 6, (1892-1896), Online publication date: 1-Jun-1996.de Reijke T, de Boer E, Kurth K and Schamhart D (2018) Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic ValueJournal of Urology, VOL. 155, NO. 2, (477-482), Online publication date: 1-Feb-1996. Volume 150Issue 6December 1993Page: 1932-1937 Advertisement Copyright & Permissions© 1993 by The American Urological Association Education and Research, Inc.Keywordskiller cells, naturalimmunotherapybladder neoplasmsBCG vaccineMetricsAuthor Information A. Böhle More articles by this author A. Thanhäuser More articles by this author A.J. Ulmer More articles by this author M. Ernst More articles by this author H.-D. Flad More articles by this author D. Jocham More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2429123395 created "2016-06-24" @default.
• W2429123395 creator A5001191488 @default.
• W2429123395 creator A5002400084 @default.
• W2429123395 creator A5019943798 @default.
• W2429123395 creator A5041286881 @default.
• W2429123395 creator A5056150399 @default.
• W2429123395 creator A5072287287 @default.
• W2429123395 date "1993-12-01" @default.
• W2429123395 modified "2023-09-23" @default.
• W2429123395 title "Dissecting the Immunobiological Effects of Bacillus Calmette-Guérin (BCG) In Vitro: Evidence of a Distinct BCG-Activated Killer (BAK) Cell Phenomenon" @default.
• W2429123395 cites W1595735008 @default.
• W2429123395 cites W1709508 @default.
• W2429123395 cites W1964586588 @default.
• W2429123395 cites W1984863487 @default.
• W2429123395 cites W1990227592 @default.
• W2429123395 cites W1997131006 @default.
• W2429123395 cites W2025292213 @default.
• W2429123395 cites W2031504100 @default.
• W2429123395 cites W2035156899 @default.
• W2429123395 cites W2053811431 @default.
• W2429123395 cites W2069612743 @default.
• W2429123395 cites W2091814508 @default.
• W2429123395 cites W229763590 @default.
• W2429123395 cites W2333193688 @default.
• W2429123395 cites W2408301264 @default.
• W2429123395 cites W2409029005 @default.
• W2429123395 cites W2412549489 @default.
• W2429123395 cites W2414572565 @default.
• W2429123395 cites W2418118083 @default.
• W2429123395 cites W2432623658 @default.
• W2429123395 cites W2460892140 @default.
• W2429123395 cites W2472680636 @default.
• W2429123395 cites W43903262 @default.
• W2429123395 cites W90860339 @default.
• W2429123395 doi "https://doi.org/10.1016/s0022-5347(17)35941-4" @default.
• W2429123395 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8230540" @default.
• W2429123395 hasPublicationYear "1993" @default.
• W2429123395 type Work @default.
• W2429123395 sameAs 2429123395 @default.
• W2429123395 citedByCount "67" @default.
• W2429123395 countsByYear W24291233952012 @default.
• W2429123395 countsByYear W24291233952013 @default.
• W2429123395 countsByYear W24291233952014 @default.
• W2429123395 countsByYear W24291233952015 @default.
• W2429123395 crossrefType "journal-article" @default.
• W2429123395 hasAuthorship W2429123395A5001191488 @default.
• W2429123395 hasAuthorship W2429123395A5002400084 @default.
• W2429123395 hasAuthorship W2429123395A5019943798 @default.
• W2429123395 hasAuthorship W2429123395A5041286881 @default.
• W2429123395 hasAuthorship W2429123395A5056150399 @default.
• W2429123395 hasAuthorship W2429123395A5072287287 @default.
• W2429123395 hasConcept C109316439 @default.
• W2429123395 hasConcept C137061746 @default.
• W2429123395 hasConcept C149532602 @default.
• W2429123395 hasConcept C154317977 @default.
• W2429123395 hasConcept C17991360 @default.
• W2429123395 hasConcept C202751555 @default.
• W2429123395 hasConcept C203014093 @default.
• W2429123395 hasConcept C22070199 @default.
• W2429123395 hasConcept C2777701055 @default.
• W2429123395 hasConcept C2778288313 @default.
• W2429123395 hasConcept C28651165 @default.
• W2429123395 hasConcept C502942594 @default.
• W2429123395 hasConcept C55493867 @default.
• W2429123395 hasConcept C71924100 @default.
• W2429123395 hasConcept C86803240 @default.
• W2429123395 hasConcept C8891405 @default.
• W2429123395 hasConceptScore W2429123395C109316439 @default.
• W2429123395 hasConceptScore W2429123395C137061746 @default.
• W2429123395 hasConceptScore W2429123395C149532602 @default.
• W2429123395 hasConceptScore W2429123395C154317977 @default.
• W2429123395 hasConceptScore W2429123395C17991360 @default.
• W2429123395 hasConceptScore W2429123395C202751555 @default.
• W2429123395 hasConceptScore W2429123395C203014093 @default.
• W2429123395 hasConceptScore W2429123395C22070199 @default.
• W2429123395 hasConceptScore W2429123395C2777701055 @default.
• W2429123395 hasConceptScore W2429123395C2778288313 @default.
• W2429123395 hasConceptScore W2429123395C28651165 @default.
• W2429123395 hasConceptScore W2429123395C502942594 @default.
• W2429123395 hasConceptScore W2429123395C55493867 @default.
• W2429123395 hasConceptScore W2429123395C71924100 @default.
• W2429123395 hasConceptScore W2429123395C86803240 @default.
• W2429123395 hasConceptScore W2429123395C8891405 @default.
• W2429123395 hasIssue "6" @default.
• W2429123395 hasLocation W24291233951 @default.
• W2429123395 hasLocation W24291233952 @default.
• W2429123395 hasOpenAccess W2429123395 @default.
• W2429123395 hasPrimaryLocation W24291233951 @default.
• W2429123395 hasRelatedWork W1994802948 @default.
• W2429123395 hasRelatedWork W2039747916 @default.
• W2429123395 hasRelatedWork W2125039950 @default.
• W2429123395 hasRelatedWork W2126966733 @default.
• W2429123395 hasRelatedWork W2376827747 @default.
• W2429123395 hasRelatedWork W2392078028 @default.
• W2429123395 hasRelatedWork W2418642723 @default.
• W2429123395 hasRelatedWork W4251449568 @default.
• W2429123395 hasRelatedWork W2023852967 @default.

• next